Skip to main content
Quest Diagnostics

HDV RNA Assays: Performance Characteristics, Clinical Utility and Challenges

HDV RNA Assays: Performance Characteristics, Clinical Utility and Challenges

Authors: Wedemeyer H, Leus M, Battersby TR, Glenn J, Gordien E, Kamili S, Kapoor H, Kessler HH, Lenz O, Lütgehetmann M, Mixson-Hayden T, Simon CO, Thomson M, Westman G, Miller V, Terrault N, Lampertico P; HDV RNA Assays Writing Group at the HBV Forum

Citation: Hepatology. 2023 Aug 28. doi: 10.1097/HEP.0000000000000584. Online ahead of print.

Specialties: Infectious Disease

Related content

Publication
Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination
On-Demand Webinar
HBV Webinar: From Screening to Functional Cure
Publication
Hepatitis C Virus Testing During Pregnancy Following Universal Screening Recommendations
Publication
Hepatitis C virus clearance cascade — United States, 2013–2022
Test FAQ
HBV screen panel with reflexes
Conference Presentation
Very low rates of hepatitis delta virus testing among a large national cohort of patients with chronic hepatitis B infection

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.